Correlation Between Tenax Therapeutics and Diffusion Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tenax Therapeutics and Diffusion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tenax Therapeutics and Diffusion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tenax Therapeutics and Diffusion Pharmaceuticals, you can compare the effects of market volatilities on Tenax Therapeutics and Diffusion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tenax Therapeutics with a short position of Diffusion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tenax Therapeutics and Diffusion Pharmaceuticals.

Diversification Opportunities for Tenax Therapeutics and Diffusion Pharmaceuticals

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Tenax and Diffusion is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Tenax Therapeutics and Diffusion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Diffusion Pharmaceuticals and Tenax Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tenax Therapeutics are associated (or correlated) with Diffusion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Diffusion Pharmaceuticals has no effect on the direction of Tenax Therapeutics i.e., Tenax Therapeutics and Diffusion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Tenax Therapeutics and Diffusion Pharmaceuticals

Given the investment horizon of 90 days Tenax Therapeutics is expected to generate 6.0 times more return on investment than Diffusion Pharmaceuticals. However, Tenax Therapeutics is 6.0 times more volatile than Diffusion Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Diffusion Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest  2,616  in Tenax Therapeutics on September 1, 2024 and sell it today you would lose (2,080) from holding Tenax Therapeutics or give up 79.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy8.33%
ValuesDaily Returns

Tenax Therapeutics  vs.  Diffusion Pharmaceuticals

 Performance 
       Timeline  
Tenax Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Tenax Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Tenax Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Diffusion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Diffusion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Diffusion Pharmaceuticals is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Tenax Therapeutics and Diffusion Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tenax Therapeutics and Diffusion Pharmaceuticals

The main advantage of trading using opposite Tenax Therapeutics and Diffusion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tenax Therapeutics position performs unexpectedly, Diffusion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will offset losses from the drop in Diffusion Pharmaceuticals' long position.
The idea behind Tenax Therapeutics and Diffusion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments